Dr. Mohamed Bidair

Dr. Mohamed Bidair
After graduating from Harvard University with a degree in computer engineering, Dr. Bidair attended medical school at McGill University in Montreal, Canada. He went on to the University of California, San Diego (UCSD) for his surgical internship and urology residency where he remained as Assistant Professor of Urology at UCSD for three years. During that time, Dr. Bidair was involved in many research projects, publications and presentations in addition to his clinical interests in stone disease, urologic oncology and laparoscopic surgery. He currently has over 100 published articles, abstracts and presentations. By 1995, Dr. Bidair became Chief of the Urology Section at the Veterans Affairs Medical Center in La Jolla, California. He entered private practice in January 1997, as a partner at Alvarado/La Mesa Urology Center. There he became the Research Division Director of his practice. By December 2001, in addition to his full-time practice in urology, Dr. Bidair acquired the role of Medical Director San Diego Clinical Trials. Dr. Bidair was a principal investigator in the Procept research studies that led to the FDA approval of Aquablation of the prostate. He has one of the highest case loads and experience in North America in performing the robotic Aquablation. Dr. Bidair is an active medical staff member in 4 hospitals in the San Diego area. He attained multiple leadership positions in the medical community including President of The San Diego Urological Society and Chief of Staff at Alvarado Hospital Medical Center. Dr. Bidair is board certified by the American Board of Urology since 1996 with recertifications in 2006 and 2016. Dr. Bidair is fluent in English, French, Arabic and Spanish.

Languages Spoken:

English, French, Arabic and Spanish

Medical School:

McGill University

Residency:

University of California, San Diego

Undergraduate:

Harvard University

Locations

Alvarado La Mesa Urology Medical Group, Inc La Mesa, CA

8881 Fletcher Parkway, Suite 250ALa Mesa, California, 91942United States
619-229-2626 | Visit Website

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only